XML 66 R7.htm IDEA: XBRL DOCUMENT v2.4.0.8
Consolidated Statements of Cash Flows (USD $)
In Thousands, unless otherwise specified
12 Months Ended
Sep. 30, 2014
Sep. 30, 2013
Sep. 30, 2012
Operating activities      
Net income $ 30,390 $ 41,104 $ 48,296
Adjustments to reconcile income from continuing operations to net cash provided by operating activities from continuing operations:      
Depreciation and amortization 16,595 17,374 14,166
Gain on early extinguishment of debt   (1,000)  
Change in fair value of earn out liability (18,390) 5,437 (664)
Stock compensation expense 12,605 13,379 12,117
Provision (benefit) for inventory allowance 271 (1,122) 884
Provision (benefit) for doubtful accounts 151 (357) 117
Deferred tax expense (benefit) 828 (6,852) (1,719)
Incremental tax benefit from exercise of common stock options and restricted stock (3,805) (8,588) (16,953)
Changes in operating assets and liabilities:      
Accounts receivable 2,211 (7,466) (1,596)
Inventory (49,488) (7,470) (132)
Prepaid and deferred taxes, current (2,829) 14,243 17,432
Prepaid expenses and other assets 2,735 (26) 458
Accounts payable (545) 6,542 (7,570)
Accrued expenses and other 9,659 (2,341) (8,534)
Profit-sharing distributions payable 425 274 (3,226)
Customer payables 12,046 (4,768) 2,510
Acquisition earn out payable   11,422 3,162
Other liabilities (1,003) (198) 205
Net cash provided by operating activities from continuing operations 11,856 46,743 52,629
Net cash used by operating activities from discontinued operations     (483)
Net cash provided by operating activities 11,856 46,743 52,146
Investing activities      
Cash paid for acquisitions and increase in goodwill and intangibles (141) (14,730) (71,796)
Purchases of property and equipment (7,539) (5,463) (6,793)
Net cash used in investing activities (7,680) (20,193) (78,589)
Financing activities      
Principal repayments of debt   (39,000)  
Repurchases of common stock (44,873)   (29,999)
Proceeds from exercise of common stock options (net of tax) 4,146 2,532 15,491
Incremental tax benefit from exercise of common stock options and restricted stock 3,805 8,588 16,953
Payment of acquisition contingent liabilities   (8,185)  
Net cash (used in) provided by financing activities (36,922) (36,065) 2,445
Effect of exchange rate differences on cash and cash equivalents 235 (158) (309)
Net (decrease) increase in cash and cash equivalents (32,511) (9,673) (24,307)
Cash and cash equivalents at beginning of year 95,109 104,782 129,089
Cash and cash equivalents at end of year 62,598 95,109 104,782
Supplemental disclosure of cash flow information      
Cash paid for income taxes 18,108 16,760 14,482
Cash paid for interest   2,034 117
Note payable issued in connection with acquisition     40,000
Contingent purchase price accrued   $ 18,390 $ 7,438